Global Monoclonal Antibodies Market PPT: Demand, Trends and Business Opportunities 2023-28

1
Global Monoclonal Antibodies Market Research and
Forecast Report 2023-2028




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Monoclonal Antibodies Market Research
Report 2023-2028 According to the latest report
by IMARC Group, titled "Monoclonal Antibodies
Market Global Industry Trends, Share, Size,
Growth, Opportunity and Forecast
2023-2028," the global monoclonal antibodies
market size reached US 207.4 Billion in
2022. Monoclonal antibodies (mAb) are produced
by a single clone of cells or cell lines and
consist of identical antibody molecules. These
antibodies can have monovalent affinity, binding
only to the same epitope. Due to their
site-specificity, these serve as essential tools
to detect or purify substances. They are being
used on a clinical level to diagnose and treat
several diseases. They are used as probes to
identify materials in laboratories or
home-testing kits. Due to their specificity to
unique epitopes, monoclonal antibodies are widely
used for diagnostic and therapeutic applications
for several diseases. Several manufacturers are
focusing on creating medications from many
classifications to treat various disorders,
including cancer and rare diseases. Monoclonal
antibodies, in combination with chemotherapeutic
drugs, are extensively being used to treat
different malignancies. Request for a PDF sample
of this report https//www.imarcgroup.com/monoclo
nal-antibodies-market/requestsample

4
Report Description and Highlights
Report Description
Global Monoclonal Antibodies Market Trends The
global market is majorly driven by the increasing
prevalence of chronic diseases, such as cancer
and cardiovascular diseases. In line with this,
the rising demand for biologics and the growing
applications of monoclonal antibodies for
targeted therapies are significantly contributing
to the market. This is attributed to the
escalating awareness about such treatments among
patients and physicians. Furthermore, various key
players are undertaking strategic initiatives to
develop and market mAb products. Apart from this,
the heavy investments by top pharmaceutical
companies in genomics research and development
activities are positively influencing the market.
Moreover, the increasing requirement for
effective and affordable therapies for cancer
treatment is catalyzing the market. Besides, an
extensive product pipeline with potential
effective therapies catering to a diverse range
of diseases is propelling the market expansion.
Additionally, the augmenting focus on the
discovery and development of novel monoclonal
antibody therapeutics to offer treatment for
complex and severe diseases is bolstering the
monoclonal antibodies market. Looking forward,
IMARC Group expects the market to reach US 307.8
Billion by 2028, exhibiting at a CAGR of 6.9
during 2023-2028. View Report TOC, Figures and
Tables https//www.imarcgroup.com/monoclonal-anti
bodies-market

5
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Production Method
• In Vivo
• In Vitro
•  
• Breakup by Source
• Murine
• Chimeric
• Humanized
• Human
• Breakup by Indication
• Cancer
• Autoimmune Diseases
• Inflammatory Diseases
• Infectious Diseases
• Others

6
Report Description and Highlights
Report Description

• Breakup by End Use
• Hospitals
• Research Institutes
• Others
• Breakup by Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

7
Report Description and Highlights
Report Description

•  
• Competitive Landscape with Key Players
• AbbVie Inc
• Amgen Inc
• Biogen Inc
• F. Hoffmann-La Roche AG
• GSK plc
• Johnson Johnson
• Merck KGaA
• Novartis AG
• Novo Nordisk A/S
• Pfizer Inc
• Sanofi S.A
• Thermo Fisher Scientific Inc
•  

8
Key Questions Answered in the Report
Report Description

• What was the size of the global monoclonal
  antibodies market in 2022?
• What is the expected growth rate of the global
  monoclonal antibodies market during 2023-2028?
• What are the key factors driving the global
  monoclonal antibodies market?
• What has been the impact of COVID-19 on the
  global monoclonal antibodies market?
• What is the breakup of the global monoclonal
  antibodies market based on the production method?
• What is the breakup of the global monoclonal
  antibodies market based on the source?
• What is the breakup of the global monoclonal
  antibodies market based on the indication?
• What is the breakup of the global monoclonal
  antibodies market based on the end use?
• What are the key regions in the global monoclonal
  antibodies market?
• Who are the key players/companies in the global
  monoclonal antibodies market?
•  

9
Table of Contents
Report Description
1    Preface2    Scope and Methodology    2.1
   Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3    Executive Summary4  
 Introduction    4.1    Overview    4.2    Key
Industry Trends5    Global Monoclonal Antibodies
Market    5.1    Market Overview    5.2  
 Market Performance    5.3    Impact of
COVID-19    5.4    Market Forecast

10
Table of Contents
Report Description
6    Market Breakup by Production Method    6.1
   In Vivo        6.1.1 Market Trends       
6.1.2 Market Forecast    6.2    In Vitro       
6.2.1 Market Trends        6.2.2 Market
Forecast7    Market Breakup by Source    7.1  
 Murine        7.1.1 Market Trends        7.1.2
Market Forecast    7.2     Chimeric       
7.2.1 Market Trends        7.2.2 Market
Forecast    7.3     Humanized        7.3.1
Market Trends        7.3.2 Market Forecast      
    Click here to visit the complete table of
content with list of figures and tables
https//www.imarcgroup.com/monoclonal-antibodies-m
arket/toc

11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
13
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
14

Contact Us